Francisco M. Pina

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prostate cancer treatment in Portugal: a nationwide analysis.

Prostate cancer treatment in Portugal: a nationwide analysis.

Journal: Scientific reports

Published: March 30, 2023

Can serum endoglin be used to improve the diagnostic performance in prostate cancer?

Can serum endoglin be used to improve the diagnostic performance in prostate cancer?

Journal: World journal of urology

Published: January 08, 2021

Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.

Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: October 26, 2019

Primary mesenchymal chondrosarcoma of the kidney: A case report and review of literature.

Primary mesenchymal chondrosarcoma of the kidney: A case report and review of literature.

Journal: Journal of cancer research and therapeutics

Published: June 13, 2018

Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.

Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: August 03, 2016

Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening?

Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening?

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: August 08, 2013

The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration.

The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 18, 2013

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Journal: BMC medicine

Published: April 27, 2012

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 23, 2012

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

Journal: PloS one

Published: February 15, 2012

Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer.

Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer.

Journal: Genetic testing and molecular biomarkers

Published: February 01, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026